Literature DB >> 14604559

A consistency test of the time trade-off.

Han Bleichrodt1, Jose Luis Pinto, Jose Maria Abellan-Perpiñan.   

Abstract

This paper tests the internal consistency of time trade-off utilities. We find significant violations of consistency in the direction predicted by loss aversion. The violations disappear for higher gauge durations. We show that loss aversion can also explain that for short gauge durations time trade-off utilities exceed standard gamble utilities. Our results suggest that time trade-off measurements that use relatively short gauge durations, like the widely used EuroQol algorithm, are affected by loss aversion and lead to utilities that are too high.

Mesh:

Year:  2003        PMID: 14604559     DOI: 10.1016/s0167-6296(03)00046-8

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  15 in total

1.  Exploring a new method for deriving the monetary value of a QALY.

Authors:  Carl Tilling; Marieke Krol; Arthur E Attema; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2015-08-20

2.  Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO.

Authors:  F E van Nooten; X Koolman; J J V Busschbach; W B F Brouwer
Journal:  Qual Life Res       Date:  2013-08-14       Impact factor: 4.147

3.  Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia.

Authors:  Keith Tolley; Catherine Goad; Yunni Yi; Penny Maroudas; Amin Haiderali; Gwilym Thompson
Journal:  Eur J Health Econ       Date:  2012-09-01

4.  The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Eur J Health Econ       Date:  2011-05-15

5.  A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema.

Authors:  Andrea L Cheville; Mously Almoza; Janice N Courmier; Jeffrey R Basford
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

6.  On the (not so) constant proportional trade-off in TTO.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2010-02-12       Impact factor: 4.147

7.  Constantly proving the opposite? A test of CPTO using a broad time horizon and correcting for discounting.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2011-04-21       Impact factor: 4.147

8.  Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.

Authors:  Diego F Ossa; Andrew Briggs; Emma McIntosh; Warren Cowell; Tim Littlewood; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

9.  The duration effect: a link between TTO and VAS values.

Authors:  Benjamin M Craig
Journal:  Health Econ       Date:  2009-02       Impact factor: 3.046

10.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.